Stocks and Investing
Stocks and Investing
Wed, November 16, 2016
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:46 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 04:46 AM ] - United States, WOPRAI
[ 04:46 AM ] - United States, WOPRAI
[ 04:46 AM ] - United States, WOPRAI
[ 04:46 AM ] - United States, WOPRAI
[ 04:46 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 01:46 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
David Risinger Downgraded (TEVA) to Hold and Decreased Target to $42 on, Nov 16th, 2016
David Risinger of Morgan Stanley, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Decreased Target from $63 to $42 on, Nov 16th, 2016.
David has made no other calls on TEVA in the last 4 months.
There are 6 other peers that have a rating on TEVA. Out of the 6 peers that are also analyzing TEVA, 3 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Douglas Tsao of "Barclays" Initiated at Hold and Held Target at $46 on, Monday, November 14th, 2016
- Sumant Kulkarni of "B of A Securities" Downgraded from Strong Buy to Hold on, Monday, November 7th, 2016
- Irina Rivkind Koffler of "Mizuho" Downgraded from Strong Buy to Hold on, Monday, October 24th, 2016
These are the ratings of the 3 analyists that currently disagree with David
- Vamil Divan of "Credit Suisse" Upgraded from Hold to Buy on, Monday, October 31st, 2016
- Derek Archila of "Oppenheimer" Upgraded from Hold to Buy on, Friday, September 2nd, 2016
- Ami Fadia of "Leerink Swann" Maintained at Buy with Decreased Target to $61 on, Wednesday, August 31st, 2016
Contributing Sources